These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 772723)

  • 1. Action of anticholinergic drugs on striatal dopamine.
    Snyder SH
    Pharmacol Ther B; 1976; 2(1):65-70. PubMed ID: 772723
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of blocking catecholamine uptake on amphetamine-induced circling behaviour in mice with unilateral destruction of striatal dopaminergic nerve terminals.
    Pycock C; Milson JA; Tarsy D; Marsden CD
    J Pharm Pharmacol; 1976 Jun; 28(6):530-2. PubMed ID: 7659
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of piroheptine, a new antiparkinson drug, on dopamine uptake into synaptosomes from corpus striatum of rat brain.
    Ohashi T; Akita H; Tamura T; Noda K; Honda F
    Arzneimittelforschung; 1972 Jun; 22(6):966-72. PubMed ID: 5068358
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of benapyrzine, a new antiparkinson drug, on dopamine uptake into corpus striatum.
    Palfreyman MG; Palfreyman ES; Clark MS
    Eur J Pharmacol; 1974 Oct; 28(2):379-83. PubMed ID: 4418659
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs.
    Groves PM; Rebec GV
    Annu Rev Psychol; 1976; 27():91-127. PubMed ID: 773267
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of anticholinergic-antiparkinsonian drugs on striatal neurotransmitter levels of rats intoxicated with soman.
    Shih TM; Capacio BR; Cook LA
    Pharmacol Biochem Behav; 1993 Mar; 44(3):615-22. PubMed ID: 8095723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally defined adrenergic agents. II. The effect of endo- and exo-2-aminobenzobicyclo-[2.2.2] octene, conformationally defined amphetamine analogs, on the uptake and release of central catecholamines.
    Bartholow RM; Eiden LE; Ruth JA; Grunewald GL; Siebert J; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):532-43. PubMed ID: 894520
    [No Abstract]   [Full Text] [Related]  

  • 9. A structure-activity study of the transport sites for the hypothalamic and striatal catecholamine uptake systems. Similarities and differences.
    Eckhardt SB; Maxwell RA; Ferris RM
    Mol Pharmacol; 1982 Mar; 21(2):374-9. PubMed ID: 7099141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychoactive drugs and neurotransmitters: differentiating dopamine and norepinephrine neuronal functions with drugs.
    Snyder SH; Taylor KM; Horn AS; Coyle JT
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():359-75. PubMed ID: 4341952
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain.
    Jiang DH; Reches A; Wagner HR; Fahn S
    Neuropharmacology; 1984 Mar; 23(3):295-301. PubMed ID: 6539428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and amphetamine-induced asymmetries in striatal dopamine release and metabolism: bilateral in vivo microdialysis in normal rats.
    Glick SD; Carlson JN; Baird JL; Maisonneuve IM; Bullock AE
    Brain Res; 1988 Nov; 473(1):161-4. PubMed ID: 3208119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The acute and subchronic effects of hemantane on [3H]-dopamine reuptake in rat striatal synaptosomes ex vivo].
    Abaimov DA; Kovalev GI
    Eksp Klin Farmakol; 2007; 70(4):11-4. PubMed ID: 18078034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
    Elliott PN; Jenner P; Chadwick D; Reynolds E; Marsden CD
    J Pharm Pharmacol; 1977 Jan; 29(1):41-3. PubMed ID: 13181
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of anticholinergic drugs on striatal acetylcholine release and motor activity in freely moving rats studied by brain microdialysis.
    Watanabe H; Shimizu H
    Jpn J Pharmacol; 1989 Sep; 51(1):75-82. PubMed ID: 2810943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dopaminergic, cholinergic, and glutamatergic mechanisms in the actions of phencyclidine-like drugs.
    Johnson KM; Snell LD
    NIDA Res Monogr; 1986; 64():52-66. PubMed ID: 3086740
    [No Abstract]   [Full Text] [Related]  

  • 20. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
    Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
    Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.